Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

A 3-month stay in space causes skin thinning, disrupts hair growth, and changes muscle-related genes in mice.

Skin lymphatic vessels are essential for hair growth.

New biomaterials can improve wound healing by promoting nerve and tissue regeneration.

Some skin symptoms, like chilblain-like lesions, can help identify COVID-19 and show how the immune system is responding.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Activating the Eda/Edar pathway improves wound healing by enhancing hair follicle growth.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Talc in street cocaine can cause immune-reactive skin nodules where injected.

Skin problems are very common in people with end-stage kidney disease.

Engineered exosomes show promise for improving wound healing but face challenges in clinical use.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

An 86-year-old man had a rare tongue melanoma but refused treatment, showing the need for early cancer detection and treatment.

Eating disorders can cause hair loss.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Aloe Vera helps wounds heal faster and promotes hair growth.

Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.

Targeting blood vessels may help treat skin diseases.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Certain drugs can cause skin lupus, but stopping the drug usually helps. Vaccines work against smallpox, genital herpes, and a type of human papillomavirus. More frequent light therapy clears psoriasis faster. Certain treatments work for psoriasis and dermatitis. A specific cream effectively treats a type of skin cancer. Low iron levels aren't directly linked to chronic hair loss.

Estrogen helps improve skin aging and healing, especially in post-menopausal women.